The innovative core-shell shaped nano-micelle technology makes it possible to produce stable nano-sized micelle for various poorly soluble drugs.

Our nano-micelle could be successfully manufactured in commercial GMP scale in the form of lyophilized sterile IV formulation by adopting core-shell shaped nano-micelle technology.
The stable micelle has below 100nm particle size without any particle more than 300nm, and efficiently transferred to cancer cells by the EPR effect (Enhanced Permeation and Retention) of tumor tissue. Nano-sized micelle exhibits superior anti-cancer effects with increased maximum tolerable dose (MTD).